Preparing you with tools to manage the Codeine changes
As of the 1st of February 2018, codeine-containing medications will be prescription-only, the Therapeutic Goods Administration (TGA) has declared (1).
The decision has been driven by the serious risks associated with taking over-the-counter medicines with codeine as an active ingredient. Increased tolerance and strong withdrawal symptoms can lead to codeine addiction, posing serious long-term health risks (2).
Dr Michael Gannon from the Australian Medical Association has stated that deaths and illness from codeine use have increased in Australia and is encouraging patients with chronic pain to avoid self-treating and seek appropriate advice from their Doctors on medicines and non-medicine treatments (3).
Healthshare have partnered with Indivior to provide you with information on Opioid Dependence and its management
Free Support Guides or managing patients with Opioid Dependence
It is likely you will have some patients expressing their concern or distress about the change in regulations and its impact on their treatment.
Suboxone® – A treatment option for Opioid Dependence
- Codeine Information Hub – Therapeutic Goods Administration https://www.tga.gov.au/codeine-info-hub accessed Oct 2017
- Causes of Death Australia, 2016 – Australian Bureau of Statistics Issue 3303.0 http://www.abs.gov.au/ausstats/abs@.nsf/mf/3303.0 accessed Oct 2017
- AMA Backs TGA on Codeine – Australian Medical Association, Media Release, 10 August 2017 https://ama.com.au/sites/default/files/documents/100817%20-%20AMA%20Backs%20TGA%20on%20Codeine.pdf